Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European organization for research and treatment of cancer randomized study with cross-over

R Paridaens, L Biganzoli, P Bruning, Jan Klijn, T Gamucci, SJ Houston, R Coleman, J Schachter, A van Vreckem, R Sylvester, A Awada, J Wildiers, MJ Piccart

Research output: Contribution to journalArticleAcademicpeer-review

340 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)724-733
Number of pages10
JournalJournal of Clinical Oncology
Issue number4
Publication statusPublished - 2000

Research programs

  • EMC MM-03-86-01

Cite this